BrightGene plans to list in Hong Kong
智通财经 APP 讯，博瑞医药公告，公司拟发行 H 股股票并在中国香港联合交易所有限公司主板上市。公司将充分考虑现有股东的利益和境内外资本市场的情况，在股东大会有效期内 (即经公司股东大会审议通过之日起 24 个月或同意延长的其他期限) 选择适当的时机和发行窗口完成本次发行上市。
智通财经 APP 讯，博瑞医药 (688166.SH) 公告，公司拟发行 H 股股票并在中国香港联合交易所有限公司主板上市。公司将充分考虑现有股东的利益和境内外资本市场的情况，在股东大会有效期内 (即经公司股东大会审议通过之日起 24 个月或同意延长的其他期限) 选择适当的时机和发行窗口完成本次发行上市。
Source: 智通财经 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments